Picture of Amplia Therapeutics logo

ATX — Amplia Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Australia's Amplia Therapeutics rises on FDA nod for cancer drug trial

** Shares of Amplia Therapeutics  ATX.AX  rise as much as
1.3% to A$0.081, their highest since Jan. 5
    ** Drug developer says it has received US FDA clearance for
clinical trial of its Investigational New Drug application for
pancreatic cancer
    ** About 162,900 shares change hands, compared with the
30-day average volume of 23,835 

 (Reporting by Neha Soni in Bengaluru)
 ((Neha.Soni@thomsonreuters.com))

Recent news on Amplia Therapeutics

See all news